Biomarkers and Alzheimer’s Disease: Dr. Neil Buckholtz
Dr. Neil Buckholtz, Director of the Division of Neuroscience at the National Institute on Aging/NIH, describes how biomarkers—in blood, cerebrospinal fluid and brain imaging—are advancing our ability to detect the earliest stages of Alzheimer’s, track its progression, and determine the effectiveness of promising treatments.
Most from this category

Another Study Reveals Inflammation Accelerates Progression of Alzheimer’s Disease
alzheimershelp - December 21, 2017
Protecting Neurons Could Prevent Depression and Cognitive Deterioration Caused by Alzheimer’s
alzheimershelp - November 8, 2017
